Skip to content

Clinical trials

Idiopathic Pulmonary Fibrosis trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Idiopathic Pulmonary Fibrosis Country / region: Austria Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20092
20121
20131
20181
20201
20211
20222
20231
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting5
Terminated3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim4
Hoffmann-La Roche3
Gilead Sciences2
Andreas Guenther1
Bristol-Myers Squibb1
CSL Behring1
Dr. Christopher Lambers1
Endeavor Biomedicines, Inc.1
Neovii Biotech1
Vicore Pharma AB1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Idiopathic Pulmonary Fibrosis16
Lung Diseases, Interstitial2
Pulmonary Fibrosis2
Bronchiectasis1
Cystic Fibrosis1
Hypertension, Pulmonary1
Idiopathic Interstitial Pneumonias1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.